• EDURANT is a human immunodeficiency virus type 1 (HIV-1) specific, non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve patients 12 years of age and older and weighing at least 35 kg with HIV-1 RNA less than or equal to 100,000 copies/mL ( 1.1 ). (guidelinecentral.com)
  • In contrast to the disappointing cross-resistance news with 1592, DuPont-Merck's new non-nucleoside reverse transcriptase inhibitor (NNRTI) DMP-266 (now with the generic name "efavirenz" and trade name "Sustiva"), seems to be active against the most common resistance mutation (Y181) associated with use of nevirapine and delavirdine, the two commercially available NNRTIs. (treatmentactiongroup.org)
  • Differentiating nucleoside RTIs that tight spot at the protein's dynamic site NNRTIs acts allosterically by connecting to an alternate site away from the dynamic site known as the NNRTI pocket. (allgenericcure.com)
  • Efavirenz (Trustiva):- belongs to the NNRTI (non-nucleoside reverse transcriptase inhibitors) class of antiretrovirals. (magicinepharma.com)
  • RTIs bind the enzyme's active site, NNRTIs act allosterically by binding to a distinct site away from the active site known as the NNRTI pocket. (magicinepharma.com)
  • Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and has been shown to offer similar efficacy and a better tolerability profile with respect to central nervous system (CNS) side effects (including insomnia, depression and dizziness), rash, triglyceride elevations and severe vitamin D deficiency compared to the standard of care (efavirenz). (jnj.com)
  • Emtricitabine (Trustiva):- a synthetic nucleoside analog of cytidine, is phosphorylated by cellular enzymes to form Emtricitabine (Trustiva) 5'-triphosphate. (magicinepharma.com)
  • Zalcitabine (2′-3′-dideoxycytidine, ddC), also called dideoxycytidine, is a nucleoside analog reverse-transcriptase inhibitor (NRTI) sold under the trade name Hivid. (wikipedia.org)
  • Tenofovir Disoproxil Fumarate (Trustiva):- is an acyclic nucleoside phosphonate diester analog of adenosine monophosphate. (magicinepharma.com)
  • The aim was to study the mitochondrial toxicities in terms of peripheral neuropathy (PN), lipodystrophy (LD), hepatic steatosis, lactic academia (LA), and pancreatitis developing in AIDS cases on nucleoside analog reverse transcriptase inhibitors (NRTIs) based ART regimens. (ijstd.org)
  • Combinations usually comprise two nucleoside-analogue RTIs and one non-nucleoside-analogue RTI or protease inhibitor. (citizen-news.org)
  • Normally, nucleoside analogs are converted into nucleotide analogs by the body. (wikidoc.org)
  • Zalcitabine (2′-3′-dideoxycytidine, ddC), also called dideoxycytidine, is a nucleoside analog reverse-transcriptase inhibitor (NRTI) sold under the trade name Hivid. (wikipedia.org)
  • Zalcitabine appears less potent than some other nucleoside RTIs, has an inconvenient three-times daily frequency and is associated with serious adverse events. (wikipedia.org)
  • EDURANT is a human immunodeficiency virus type 1 (HIV-1) specific, non-nucleoside reverse transcriptase inhibitor (NNRTI) indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in treatment-naïve patients 12 years of age and older and weighing at least 35 kg with HIV-1 RNA less than or equal to 100,000 copies/mL ( 1.1 ). (nih.gov)
  • Reverse transcriptase inhibitors (RTIs) are a class of antiretroviral drug used to treat HIV infection. (wikidoc.org)
  • RTIs inhibit activity of reverse transcriptase , a viral DNA polymerase enzyme that HIV needs to reproduce. (wikidoc.org)
  • RTIs block reverse transcriptase's enzymatic function and prevent completion of synthesis of the double-stranded viral DNA thus preventing HIV from multiplying. (wikidoc.org)
  • Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are the third class of antiretroviral drugs that were developed. (wikidoc.org)
  • TMC125 is an experimental non-nucleoside reverse transcriptase inhibitor (NNRTI) being developed by Tibotec. (ubc.ca)
  • Non-nucleoside RTIs include nevirapine, efavirenz and etravirine. (nih.gov)